Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Retrospective Cohort Study of Lenalidomide Monotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) to Generate a Historical Control for Clinical Trial MOR208C203 (RE-MIND)

NCT04150328 is registered in ClinicalTrials.gov with MorphoSys AG as lead sponsor.

NCT NCT04150328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04150328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Retrospective Cohort Study of Lenalidomide Monotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) to Generate a Historical Control for Clinical Trial MOR208C203 (RE-MIND)
Lead sponsor
MorphoSys AG
Phase
Observational
Overall status
Completed
Start date
April 12, 2019
Completion date
August 25, 2020
Enrollment
490 (actual)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b cell lymphoma